Reconstruction and Prevention: Nanotechnology and Tissue Engineering Approaches for Cancer Patients

Cancer is a complex disease responsible for one-in-sixth deaths. Various environmental contaminants: heavy metals, synthetic organic dyes, asbestos, polychlorinated biphenyls (PCBs), and polycyclic aromatic hydrocarbons are carcinogenic in nature. This paper investigates the potential of nanotechnology in tissue repair and cancer prevention by environmental remediation of carcinogenic pollutants. Solid lipid nanoparticles, including liposomes, are promising candidates for targeted drug delivery and tissue engineering applications. These nanocarriers can be engineered to selectively bind to diseased cells, delivering therapeutic drugs and potentially facilitating tissue repair processes. The development of those nanoparticles can benefit from combining it with Artificial Intelligence, i.e. AI can help to determine the shape and the size of the solid lipid nanoparticles targeting damaged tissues, and more importantly their biocompatibility to prevent further harm to the already damaged tissues. Molecular imaging techniques used for early detection and monitoring of carcinogenic cells can identify areas of damaged tissue with high sensitivity. This information can then be used to guide the targeted delivery of nanocarriers to the tumor site. Beyond drug delivery and tissue engineering applications, nanotechnology holds potential for cancer prevention strategies by environmental remediation of known carcinogenic pollutants. For example, ferric oxide nanoparticles have been shown to eliminate cadmium and arsenic from toxic substances.